# A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)

> **NCT01191268** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 884 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine
- **DRUG:** LY2189265
- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT01191268
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-09
- **Target enrollment:** 884 (ACTUAL)
- **Last updated:** 2014-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01191268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01191268, "A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01191268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*